Jun 18, 2026
16 MIN READ

Ozempic Dosing: What Dose Starts Working and How Long Does It Take to See Results?

Semaglutide typically begins reducing appetite within days, but meaningful weight loss usually appears after 4–8 weeks of treatment. PlexusDx compounded semaglutide starts at $149/month with flexible dosing tailored to your response.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 18, 2026
16 MIN READ

ozempic dosing: what dose starts working and how long does it take to see result — PlexusDx GLP-1 education

Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic and Wegovy, works by activating GLP-1 receptors in your brain to lower hunger signals and stabilize blood sugar. Most patients notice appetite suppression within the first week, but the timeline to visible weight loss varies based on starting dose, metabolism, and lifestyle factors. Understanding what to expect helps you stay consistent with treatment.

How Semaglutide Dosing Works: Starting Low and Titrating Up

Semaglutide treatment follows a titration protocol, meaning you begin at a low dose and increase gradually every 4 weeks. The standard starting dose is 0.25 mg weekly, followed by increases to 0.5 mg, 1.0 mg, 1.7 mg, and potentially 2.4 mg. This stepped approach allows your body to adapt and helps minimize nausea and gastrointestinal side effects that can occur with rapid dose escalation.

The timeline for dose increases is flexible and depends on how well you tolerate each level. Some patients stay at a lower maintenance dose if they achieve their goals and feel comfortable, while others continue increasing to maximize appetite suppression. PlexusDx works with you to find the right dose for your body, and your dose may need to go up—but your price won't, because PlexusDx keeps medication costs flat at $149/month for compounded semaglutide injection across all dose tiers.

When Does Semaglutide Start Working? Timeline for Appetite and Weight Changes

Appetite suppression typically begins within 2–5 days of your first injection as semaglutide accumulates in your bloodstream. Many patients report eating less at meals and reduced cravings for snacks or sugary foods during this initial window. However, meaningful weight loss—defined as 5% or more of body weight—usually becomes noticeable between weeks 4 and 8 when your dose has escalated to therapeutic levels.

Clinical trials show that patients on semaglutide lose an average of 5–10% of body weight by 12 weeks and 10–15% by 6 months. Peak weight loss effects typically continue through month 4–6 of treatment. Individual results depend on starting weight, adherence, diet quality, physical activity, and genetic factors that influence how efficiently your body responds to GLP-1 therapy.

Why Genetic Testing Matters: Personalized Response to Semaglutide

Not everyone responds to semaglutide at the same rate or dose because genetic variations affect how your body processes GLP-1 signals. Key genetic variants in the GLP1R gene (rs6923761), FTO gene (rs9939609), and MC4R gene (rs17782313) influence appetite regulation, weight set point, and medication efficacy. PlexusDx Precision Peptide Genetic Test identifies these peptide-pathway variants to predict your individual response profile.

By understanding your genetic predispositions, PlexusDx can recommend whether you're likely to respond strongly to lower doses or may benefit from higher maintenance levels. Patients with favorable GLP1R variants often see results faster, while those with certain FTO variants may require longer titration or higher final doses to achieve the same effect. This personalized approach, available as a $99 add-on after your first month, removes guesswork from dosing decisions.

What to Expect During Your First Month: Realistic Expectations

Week 1 after your first 0.25 mg injection, most patients notice reduced hunger—some describe it as 'forgetting' to eat lunch or feeling full after smaller portions. Mild nausea is possible in the first few days as your system adjusts; this typically resolves within a week. You may also experience changes in digestion, such as slower gastric emptying, which naturally contributes to prolonged fullness.

By week 4, when your dose increases to 0.5 mg, weight loss momentum begins to build as your appetite suppression deepens. Many patients see 2–4 pounds of loss during this first month, though weight loss varies. If side effects feel manageable and hunger is well-controlled, you're on track. If nausea is bothersome, staying at your current dose for an extra week or two before increasing is a reasonable adjustment—PlexusDx providers work with you on individualized pacing.

Monthly Progression: What Month 2, 3, and Beyond Look Like

Months 2–3 represent the rapid weight loss phase for most patients. As your dose climbs toward 1.0–1.7 mg, appetite suppression intensifies and weight loss typically accelerates to 2–4 pounds per week. During this period, your new normal becomes eating 50–60% less than before, and food cravings often diminish dramatically. This is also when many patients report improved energy, better sleep, and reduced blood sugar swings.

By month 4–6, weight loss begins to slow as you approach your body's new equilibrium. This is normal and expected; some patients reach their goal weight by this point, while others continue losing steadily. Maintenance dosing (often 1.7–2.4 mg weekly) keeps appetite suppression stable long-term. PlexusDx compounded semaglutide ensures continuous access without insurance barriers, no membership fees, and HSA/FSA eligibility—all at the same flat $149/month price regardless of your dose level.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in the first month of semaglutide?

Most patients lose 2–4 pounds during month 1, though initial loss is partly water weight as your body adjusts to reduced calorie intake. Significant fat loss accelerates in months 2–3 when your dose reaches therapeutic levels. Individual results depend on starting weight, diet quality, exercise, and genetic factors affecting medication response.

What's the difference between starting at 0.25 mg and jumping to a higher dose?

Starting at 0.25 mg allows your body to build tolerance gradually, reducing nausea and GI side effects that come with rapid dose escalation. Skipping early doses increases the risk of intolerable side effects that may force you to pause treatment. The standard 4-week titration is designed by clinical evidence to balance safety and efficacy.

Can I stay on a low dose of semaglutide if it's working for me?

Yes, absolutely. If you achieve appetite suppression and weight loss goals at 0.5 mg or 1.0 mg, staying at that maintenance dose is a valid choice. PlexusDx supports individualized dosing based on your response, not a one-size-fits-all protocol. Your dose may need to go up, but it doesn't have to—and your price stays flat at $149/month either way.

What if I don't see results after 8 weeks?

If you've reached 1.0 mg or higher and hunger suppression isn't significant, this may indicate your body has lower sensitivity to GLP-1 signaling—a situation where genetic testing becomes valuable. PlexusDx Precision Peptide Genetic Test ($99 add-on) identifies GLP1R and FTO variants that predict medication response, helping providers decide whether a higher dose, different compound (like tirzepatide), or dual-compound approach is best for you.

Does PlexusDx test my genes before I start semaglutide?

PlexusDx Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment. This peptide-pathway test analyzes 14 metabolic pathways and 49 peptides, including GLP1R, GIPR, FTO, and MC4R variants, to predict your individual response profile and guide personalized dosing or medication selection.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves